Ellen K Ritchie (Ellen Ritchie)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Sickle Cell Disease

Psychometric Properties

Cognitive Impairment

Top Venues

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Richard Grunwald, Ellen K Ritchie, Elisa Rumi, Albert Assad, J E Hamer-Maansson, Jingbo Yu, Tricia Kalafut, Evan Braunstein, Francesco Passamonti
Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched-cohort analysis. EJHaem 5 (4) (2024)
Michael Richard Grunwald, Ellen K Ritchie, Elisa Rumi, Albert Assad, J E Hamer-Maansson, Jingbo Yu, Tricia Kalafut, Evan Braunstein, Francesco Passamonti
Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: A matched-cohort analysis. EJHaem 5 (4) (2024)
Ghaith Abu-Zeinah, Silvana Di Giandomenico, Daniel C Choi, Tatiana Cruz, Katie Erdos, Elwood Taylor, Ellen K Ritchie, Richard T Silver, Joseph Michael Scandura
Hematopoietic fitness of JAK2V617F myeloproliferative neoplasms is linked to clinical outcome. Blood advances 6 (18) (2022)
Ellen K Ritchie, Heidi D Klepin, Elizabeth Storrick, Brittny Major, Jennifer G Le-Rademacher, Martha Wadleigh, Alison Walker, Richard A Larson, Gail J Roboz
Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101. Blood advances 6 (12) (2022)
Ellen K Ritchie, Anas Al-Janadi, Craig Kessler, Robyn Scherber, Tricia Kalafut, Haobo Ren, Ruben A Mesa
Patient-reported outcomes of patients with myelofibrosis or essential thrombocythemia enrolled in the MOST study. Leukemia & lymphoma (2022)